
Mankind Pharma Limited, one of India’s leading pharmaceutical companies, has entered into an exclusive in-licensing and marketing agreement with Chongqing Chenan Biopharmaceutical Co., Ltd., China, for the commercialisation of two insulin analogues, Insulin Degludec and Insulin Degludec + Aspart Combination, in India. The partnership marks another significant step in Mankind Pharma’s strategy to strengthen its [...] The post Mankind Pharma Enters into Exclusive In-Licensing Agreement for Insulin Degludec and Insulin Degludec + Aspart Combination for India appeared first on FM Live .
Fm Live
Original source
mankind pharma
Check live status on DownRightNow

